An Open Label SLV308 Safety Extension to Study S308.3.003 in Early PD Patients

419, Birmingham

413, Oceanside

408, Oxnard

422, New Haven

403, Boca Raton

411, Sarasota

421, Augusta

410, Fort Wayne

417, Lexington

405, Boston

420, Boston

406, Minneapolis

412, Raleigh

Site 402, Dayton

303, Bedford Park

304, Cheltenham

301, Concord

Site 300, East Gosford

302, Westmead

315, Kralove

313, Olomouc

310, Ostrava

314, Ostrava

312, Pardubice

311, Pilsen

320, Tallinn

321, Tartu

332, Bochum

331, Göttingen

329, Heidelberg

330, Leipzig

328, Lübeck

326, Wiesbaden

338, Bangalore

339, Hyderabaad

337, Kerala

336, Mumbai

340, Mumbai

348, Grosseto

346, Lido di Camaiore

344, Pescara

343, Roma

345, Roma

428, Kaunas

427, Vilnius

429, Vilnius

355, Kelantan

357, Kuala Lumpur

356, Pulau Pinang

361, 's-Hertogenbosch

364, Eindhoven

360, Groningen

362, Groningen

373, Gdansk

371, Kalisz

369, Katowice

365, Krakow

368, Leszno

366, Lublin

370, Mosina

376, Coimbra

375, Lisbon

377, Cape Town

378, Cape Town

380, Gauteng

381, Pretoria

379, Sandton

388, Hualien City

387, Kaohsiung City

389, Kaohsiung Hsien

386, Kwei-Shan

385, Taipei

391, Bangkok

393, Bangkok

394, Ubonratchathani